https://www.thebody.com/collection/eyes-on-the-end
AIDSVu map that depicts state-by-state rates of people living with HIV in the U.S.
Features

The United States Says It'll End Its HIV Epidemic. We're Watching.

We're telling the stories of the people and places that will be profoundly affected by the "Ending the HIV Epidemic" plan as it unfolds, and seeking to answer the question: Can this plan truly end HIV transmission in the U.S.?

By Kenyon Farrow

Featured

Biden Harris
Features

Biden Actually Has a House and Senate Majority. So What Should We Push For?

Advocates say that a big fat COVID bill must come first, followed by a Medicare public option. (Oh ... and then there’s impeachment.)

By Tim Murphy
HIV community members protest the use of molecular surveillance onstage at the 2019 United States Conference on AIDS
Features

What Exactly Is Molecular Surveillance—and Why Are HIV Advocates Freaking Out Over It?

It’s a way of analyzing the genetic makeup of different people’s HIV to draw connections among cases for prevention purposes—but some are worried it could be used to criminalize people with HIV.

By Tim Murphy
Demetre Daskalakis
News Analysis

Between COVID and a New Administration, What's to Come for the “Ending the HIV Epidemic” Plan?

The pandemic has definitely delayed things, say advocates, but overall the goal of stopping HIV in the U.S. by 2025 is still on track.

By Tim Murphy
vaccine virus
Features

I Am Jealous of COVID-19

What would happen if we doubled the budget for an HIV cure? It would still be far less money than has already been spent on COVID-19 vaccines. Both are worthy of investment.

By Juan Michael Porter II
USA red ribbon
News

New Draft of a National HIV Strategy Doubles Down on Plan to End the U.S. Epidemic

The newly updated plan, which is open for public comment until Dec. 14, is more closely in line with the Ending the HIV Epidemic initiative, and includes efforts to fight stigma and racial disparities.

By Larry Buhl
Rochelle Walensky, M.D., M.P.H., speaks during a news conference at the Queen Theater in Wilmington, Delaware, on Dec. 8, 2020
Features

HIV Ally Rochelle Walensky Will Lead the CDC Under Biden. Can She Rehab the Agency After Four Years of Trump?

Walensky is an expert on implementing health care solutions and is widely respected among HIV advocates. She’s also the second recent senior CDC hire who’s white, at a time when health crises are hitting people of color especially hard.

By Tim Murphy
Demetre
News

NYC’s Leather Daddy HIV Czar Is Going to the CDC—And Advocates Nationwide Are Thrilled

Demetre Daskalakis, M.D., who led New York City through seven years of bold programs that made the city’s HIV rates plunge, will take his prevention vision national starting Dec. 21.

By Tim Murphy
VOCAL-NY advocates
Features

New York Advocates Say Cuomo Is Allowing a Drug Use Disaster to Happen During COVID

Echoing nationwide reports, they cite more overdose deaths and dirty-needle use—and say that the governor could reverse much of the crisis with a stroke of the pen.

By Tim Murphy
pharmacist and patient
Features

Pharmacies Grapple With Red Tape as States Try to Allow Pharmacists to Prescribe PrEP

Getting pre-exposure prophylaxis (PrEP) to more people who need it will take some legislative teamwork to overcome barriers, such as lack of incentive for pharmacists.

By Larry Buhl
United States pandemic
Viewpoints

The COVID-19 Pandemic Needs To Be Treated Like the National Security Threat It Is

Until the United States takes public health seriously, consider pandemics a national security threat.

By Tuyishime Claire Gasamagera